Imvax
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma (NCT04485949) | Imvax | 2023-03-20 |
Track Imvax automatically
Every clearance here is in the API, with alerts when new ones post.